BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38734714)

  • 21. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL; Dye T; Grace C; Hiraoka M
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
    Zong LJ; Zhang YZ; Yang XS; Jiang J; Cui BX; Qiao YB; Li L; Jiang K; Zhang WJ; Kong BH; Shen K
    Asian Pac J Cancer Prev; 2015; 16(5):1907-12. PubMed ID: 25773843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
    CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.
    Ferreccio C; Barriga MI; Lagos M; Ibáñez C; Poggi H; González F; Terrazas S; Katki HA; Núñez F; Cartagena J; Van De Wyngard V; Viñales D; Brañes J
    Int J Cancer; 2013 Feb; 132(4):916-23. PubMed ID: 22684726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer diagnosis based on modified uniform local ternary patterns and feed forward multilayer network optimized by genetic algorithm.
    Fekri-Ershad S; Ramakrishnan S
    Comput Biol Med; 2022 May; 144():105392. PubMed ID: 35299043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybridization of Deep Learning Pre-Trained Models with Machine Learning Classifiers and Fuzzy Min-Max Neural Network for Cervical Cancer Diagnosis.
    Kalbhor M; Shinde S; Popescu DE; Hemanth DJ
    Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cell classification with deep-learning algorithms.
    Xu L; Cai F; Fu Y; Liu Q
    Med Biol Eng Comput; 2023 Mar; 61(3):821-833. PubMed ID: 36626113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of deep learning based diagnostic system to cervical squamous intraepithelial lesions recognition in colposcopy images.
    Yuan C; Yao Y; Cheng B; Cheng Y; Li Y; Li Y; Liu X; Cheng X; Xie X; Wu J; Wang X; Lu W
    Sci Rep; 2020 Jul; 10(1):11639. PubMed ID: 32669565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of the Triple Test Versus Colposcopy for the Diagnosis of Premalignant and Malignant Cervical Lesions.
    Fatahi Meybodi N; Karimi-Zarchi M; Allahqoli L; Sekhavat L; Gitas G; Rahmani A; Fallahi A; Hassanlouei B; Alkatout I
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3501-3507. PubMed ID: 33369445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand.
    Perksanusak T; Sananpanichkul P; Chirdchim W; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(12):4977-80. PubMed ID: 26163625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
    Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
    AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A deep learning-based method for cervical transformation zone classification in colposcopy images.
    Cao Y; Ma H; Fan Y; Liu Y; Zhang H; Cao C; Yu H
    Technol Health Care; 2023; 31(2):527-538. PubMed ID: 36093645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of Pap-smear cell images using deep convolutional neural network accelerated by hand-crafted features.
    Kupas D; Harangi B
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():1452-1455. PubMed ID: 36083935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening.
    Wentzensen N; Lahrmann B; Clarke MA; Kinney W; Tokugawa D; Poitras N; Locke A; Bartels L; Krauthoff A; Walker J; Zuna R; Grewal KK; Goldhoff PE; Kingery JD; Castle PE; Schiffman M; Lorey TS; Grabe N
    J Natl Cancer Inst; 2021 Jan; 113(1):72-79. PubMed ID: 32584382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.
    Ronco G; Zappa M; Franceschi S; Tunesi S; Caprioglio A; Confortini M; Del Mistro A; Carozzi F; Segnan N; Zorzi M; Giorgi-Rossi P;
    Eur J Cancer; 2016 Nov; 68():148-155. PubMed ID: 27755998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
    Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
    Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Study of Smart Scope® Visual Screening Test with Naked Eye Visual Screening and Pap Test.
    Rahatgaonkar V; Uchale P; Oka G
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3509-3515. PubMed ID: 33369446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.